Clinical Research Directory
Browse clinical research sites, groups, and studies.
High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium
Sponsor: Samsung Medical Center
Summary
The aim of this study is to compare safety and efficacy between the aggressive treatment with combination of high-intensity statin and ezetimibe and the current standard lipid lowering treatment in asymptomatic patients with presence of coronary calcification.
Official title: Comparison of Efficacy and Safety of High-Intensity Statin and Ezetimibe Combination Versus StanDard carE in AsymptomatiC PatIentS wIth Presence of COroNary Artery CALCIUM (DECISION-CAL)
Key Details
Gender
All
Age Range
40 Years - Any
Study Type
INTERVENTIONAL
Enrollment
6000
Start Date
2023-07-03
Completion Date
2030-06-30
Last Updated
2025-01-14
Healthy Volunteers
No
Interventions
Guideline directed statin therapy
At least moderate intensity statin, recommended by the current guideline based on the ASCVD risk
High intensity statin plus ezetimibe therapy
Rosuvastatin 20 mg + Ezetimibe 10 mg
Locations (1)
SamsungMedicalCenter
Seoul, South Korea